NSPR – inspiremd inc. (US:NASDAQ)
Stock Stats
News
InspireMD (NYSE:NSPR) is now covered by analysts at Maxim Group. They set a "buy" rating and a $6.00 price target on the stock.
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
InspireMD Announces Publication of the C-GUARDIANS Pivotal Trial Manuscript in the Journal of the American College of Cardiology (JACC)
InspireMD (NASDAQ:NSPR) shareholders have endured a 81% loss from investing in the stock five years ago [Yahoo! Finance]
Landmark CREST-2 Study Published in the New England Journal of Medicine Highlights the Benefits of Carotid Artery Stenting
Form SCHEDULE 13G/A InspireMD, Inc. Filed by: Rosalind Advisors, Inc.
Form 4 InspireMD, Inc. For: Jan 15 Filed by: Gleason Shane Thomas
Form SCHEDULE 13G/A InspireMD, Inc. Filed by: Aberdeen Group plc
Form 4 InspireMD, Inc. For: Jan 14 Filed by: Tommasoli Andrea
Form 4 InspireMD, Inc. For: Jan 14 Filed by: Ward Scott R.
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.